Pulmonary eosinophilic syndromes characterization. The role of peripheral eosinophilia as a marker of clinical evolution

H. Novais e Bastos, P. Mota, N. Melo, M. Beltrão, O. Sokhatska, C. Palmares, A. Morais (Porto, Braga, Portugal)

Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Session: Diffuse parenchymal lung disease II
Session type: Thematic Poster Session
Number: 3649
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Novais e Bastos, P. Mota, N. Melo, M. Beltrão, O. Sokhatska, C. Palmares, A. Morais (Porto, Braga, Portugal). Pulmonary eosinophilic syndromes characterization. The role of peripheral eosinophilia as a marker of clinical evolution. Eur Respir J 2012; 40: Suppl. 56, 3649

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical analysis of acute exacerbation of COPD cases with increased eosinophilic granulocytes in peripheral blood
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

Distinct clinical and pathological phenotypes in IPF
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


The role of systemic markers of inflammation in bronchiectasis.
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019


The importance of inflammatory markers in sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Differential diagnosis of pulmonary eosinophilia
Source: Eur Respir Monogr 2022; 95: 19-36
Year: 2022


Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012



Frequencies and dynamics of peripheral immune cell subsets in idiopathic pulmonary fibrosis: Preliminary results and clinical implications
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012


Possible role of IL-25 in eosinophilic lung inflammation in patients with eosinophilic pneumonia
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017


Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014


Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Source: Eur Respir J 2007; 30: 835-839
Year: 2007



Peripheral blood eosinophilia and clinical phenotype in Bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018

Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019


Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 102s
Year: 2006

Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment
Source: Virtual Congress 2020 – When the lung gets stiff
Year: 2020


Comprehensive evaluation of airway involvement in pulmonary sarcoidosis
Source: ERJ Open Res, 3 (1) 00105-2016; 10.1183/23120541.00105-2016
Year: 2017



Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19.
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021


Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002